InsiderFlow

Camille L Bedrosian

AMLX

Camille L Bedrosian serves as officer: Chief Medical Officer at Amylyx Pharmaceuticals, Inc. (AMLX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

6 trades

$568.0K

Net Position

Net Seller

$568.0K

Companies Traded

1

AMLX

Active Period

Sep 2024 – Mar 2026

6 total trades

Most Recent

Sell AMLX

Mar 4, 2026 · $188.4K

Camille L Bedrosian's Insider Trading at Amylyx Pharmaceuticals, Inc. (AMLX)

Buys

0 · $0.00

Sells

6 · $568.0K

Total Shares Bought

0

Total Shares Sold

60,829

AMLX Price Chart
Loading chart...
DateTypeSharesAvg PriceValueShares After
Mar 4, 2026Sell12,922$14.58$188.4K169,295
Dec 1, 2025Sell6,580$14.35$94.4K0
Sep 30, 2025Sell12,039$14.58$175.5K0
Mar 31, 2025Sell12,425$3.47$43.1K0
Dec 2, 2024Sell5,421$5.54$30.0K0
Sep 30, 2024Sell11,442$3.20$36.6K0